Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study
2 other identifiers
interventional
316
1 country
1
Brief Summary
The 4T program encompasses: Teamwork, Targets, Technology, and Tight Range. These methods will help patients better manage their condition of Type 1 Diabetes with improved patient-reported outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2020
CompletedFirst Posted
Study publicly available on registry
April 7, 2020
CompletedStudy Start
First participant enrolled
June 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMarch 3, 2026
March 1, 2025
5 years
April 3, 2020
February 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in rise of HbA1c
Rise in HbA1c (a measure of blood sugar levels over the previous 3 months) as a measurement of the effect of 4T education and care. Collected through a blood sample.
Baseline, 6 months and 12 months post-diagnosis
Secondary Outcomes (11)
Change in CGM Benefits and Burden Scale
Baseline, 3, 6, 9 and 12 months
Change Diabetes Distress Scale
Baseline, 3, 6, 9 and 12 months
Change in Diabetes Technology Attitude Scale
Baseline, 3, 6, 9 and 12 months
Change in Parental Diabetes Distress Scale
Baseline, 3, 6, 9 and 12 months
Change in Promise Global Health Scale
Baseline, 3, 6, 9 and 12 months
- +6 more secondary outcomes
Other Outcomes (1)
T1D Patients receiving 4T education and care monitored on a step-down cadence in study 2, will achieve an HBA1c non-inferior to weekly review
4-12 month trajectory in study 2
Study Arms (1)
T1D Patients
OTHERParticipants will wear a Continuous Glucose Monitor (CGM) with remote data monitoring
Interventions
CGM data will be used to create customized weekly or monthly feedback to the participant/family by secure MyChart message.
Eligibility Criteria
You may qualify if:
- All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
- Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
- Individuals who agree to CGM data integration into the EMR for remote monitoring
- Age: six months to \< 21 years of age
- Patient or guardian must own and operate an Apple compatible device (e.g., iPhone or iPod Touch) to allow for the Dexcom app and CGM data transmission to the hospital server-based remote monitoring system.
- Dr Prahalad's LPCH Auxiliary Fund grant (in addition to the R18) has resources to support iPod Touch/iPhone purchases for participants who do not have these.
- o For the Exercise Ancillary study: 11 to \< 21 years of age (the activity tracker is not validated for younger children) English and Spanish-Speaking (Study 2)
You may not qualify if:
- Diabetes diagnosis other than T1D
- Diagnosis of diabetes \> one month prior to initial visit
- Individuals with the intention of obtaining diabetes care at another clinic
- Individuals who do not consent to CGM use, CGM data integration, remote monitoring
- Individuals \> 21 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Franziska Katherine Bishop
Steamboat Springs, Colorado, 80487, United States
Related Publications (6)
Prahalad P, Scheinker D, Desai M, Ding VY, Bishop FK, Lee MY, Ferstad J, Zaharieva DP, Addala A, Johari R, Hood K, Maahs DM. Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes. Nat Med. 2024 Jul;30(7):2067-2075. doi: 10.1038/s41591-024-02975-y. Epub 2024 May 3.
PMID: 38702523RESULTZaharieva DP, Ritter V, Bishop FK, Desai M, Addala A, Prahalad P, Riddell MC, Maahs DM; 4T Study Group. Physical Activity Is Associated With Improved Glycemic Outcomes in Newly Diagnosed Youth With Type 1 Diabetes: 4T Exercise Program. Diabetes Care. 2025 Oct 1;48(10):1752-1760. doi: 10.2337/dc25-0765.
PMID: 40590663RESULTAddala A, Ritter V, Schneider-Utaka AK, Alamarie SA, Pang E, Balistreri I, Shaw B, Bishop FK, Zaharieva DP, Prahalad P, Desai M, Maahs DM, Hood KK; 4T Team. Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis. Diabetes Obes Metab. 2025 Feb;27(2):933-943. doi: 10.1111/dom.16093. Epub 2024 Nov 27.
PMID: 39604317RESULTFerstad JO, Prahalad P, Maahs DM, Zaharieva DP, Fox E, Desai M, Johari R, Scheinker D. Smart Start - Designing Powerful Clinical Trials Using Pilot Study Data. NEJM Evid. 2024 Feb;3(2):EVIDoa2300164. doi: 10.1056/EVIDoa2300164. Epub 2024 Jan 22.
PMID: 38320487DERIVEDZaharieva DP, Ding VY, Addala A, Prahalad P, Bishop F, Hood KK, Desai M, Wilson DM, Buckingham BA, Maahs DM. Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management. Diabetes Technol Ther. 2024 Mar;26(3):176-183. doi: 10.1089/dia.2023.0405.
PMID: 37955644DERIVEDAddala A, Ding V, Zaharieva DP, Bishop FK, Adams AS, King AC, Johari R, Scheinker D, Hood KK, Desai M, Maahs DM, Prahalad P; Teamwork, Targets, Technology, and Tight Control (4T) Study Group. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring. JAMA Netw Open. 2023 Apr 3;6(4):e238881. doi: 10.1001/jamanetworkopen.2023.8881.
PMID: 37074715DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
David M Maahs, MD, PhD
Lucile Packard Children's Hospital; Stanford University, School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Pediatric Endocrinology
Study Record Dates
First Submitted
April 3, 2020
First Posted
April 7, 2020
Study Start
June 18, 2020
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
March 3, 2026
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share